Related Experiment Video
Updated: May 4, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Implementation of a pharmacist-supervised outpatient diabetes treatment clinic
Izabela A Collier1, David M Baker
1Izabela A. Collier, Pharm.D., CDE, is Clinical Assistant Professor of Pharmacy Practice; and David M. Baker, B.S.Pharm., M.B.A., J.D., is Assistant Professor of Pharmacy Administration, College of Pharmacy, Western New England University, Springfield, MA.
Purpose:
The implementation of a pharmacist-managed Veterans Affairs (VA) clinic for high-risk patients with type 2 diabetes is described, including a review of first-year performance data.
Summary:
As part of VA's ongoing initiative to improve chronic disease management by creating multidisciplinary Patient-Aligned Care Teams (PACTs) that include clinical pharmacy specialists, an outpatient diabetes treatment clinic was implemented at a VA site in Massachusetts. Operated two days weekly, the clinic provides continuity of care between physician visits by applying standard protocols and procedures for insulin therapy; oral medication and insulin doses are adjusted according to self-monitored blood glucose values and other health data transmitted by patients via telephone or secure messaging system. The clinic pharmacist monitors patients' progress toward attainment of glycosylated hemoglobin (HbA1c) goals and provides frequent followup and education to prevent hypoglycemia. During its first year of operation, the clinic enrolled 160 veterans. Among 85 patients included in a three-month review of outcomes data, the mean ± S.D. HbA1c concentration declined by more than one percentage point (from 9.12% ± 1.41% to 7.94% ± 1.18%). Further HbA1c improvements were documented in a subset of 46 patients followed for six months after clinic enrollment, with no episodes of severe hypoglycemia.
Conclusion:
An outpatient clinic successfully integrated a pharmacist into a multidisciplinary PACT focused on veterans with poorly controlled type 2 diabetes. The clinic's initial experience suggests that frequent pharmacist interventions have a positive impact in promoting appropriate insulin use in this high-risk patient population.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia

